Articles liés à Artificial Intelligence and Machine Learning in Drug...
Synopsis
Step into the riveting pages of Artificial Intelligence and Machine Learning in Drug Design and Development and unravel the impact of AI and machine learning in the world of medicine. The book instills intricate concepts on the future of medicine, unlocking potential in AI and ML, and breakthroughs in healthcare. AI helps in predicting a much broader chemical pallet for the best molecules for drug testing and delivery. Discover how cutting-edge technologies develop drug discovery processes and impact the pharmaceutical industry, healthcare, and patients' well-being.
Whether you are a researcher, scientist, or industry professionals, the book compromises of 19 chapters providing drug design methods and development. Chapters present various AI techniques in drug discovery and challenges encountered in implementing AI in docking algorithms. Discover the future applications of robotics and AI in healthcare. Furthermore, Find out different uses of machine learning algorithms and discussions of challenges, techniques, and discoveries using ML tools and techniques in drug development.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
À propos de l?auteur
Abhirup Khanna is an accomplished professional currently working as an assistant professor at the University of Petroleum and Energy Studies, Dehradun, India. He is an alumnus of The University of Melbourne, Australia. He has authored two books and numerous research publications in the areas of AI, blockchain technology, Internet of Things, and Cloud Computing for international journals and conferences. His research profile demonstrates his commitment to pushing the boundaries of AI and blockchain technology and his potential to drive transformative changes in these fields.
May El Barachi, PhD, is the Director of Computer Science & IT Programs at the University of Wollongong in Dubai, UAE. An Egyptian-Canadian computer scientist, and smart technology expert with degrees in telecom, engineering, computer engineering, and computer science, Dr. El Barachi holds leadership roles in teaching/learning and research. In her current role, she defines the research strategy for the faculty and ensures that the right ecosystem is established for conducting high-impact research.
Sapna Jain, PhD, is an assistant professor at the University of Petroleum and Energy Studies, Dehradun, India. She has earned her PhD in 'Synthesis of novel bioactive compounds' from Delhi University. She has published various research papers in renowned national and international journals, as well as two patents concerning the application of a synergistic combination of synthetic and natural products as an antifungal agent.
Manoj Kumar, PhD, is an associate professor at the University of Wollongong in Dubai, UAE as well as the Research Head for Network and Cyber Security Cluster at the university. He obtained his PhD from The Northcap University, Haryana, India. Dr. Kumar has more than 14 years of research, teaching, and corporate experience, and has published more than 175 research articles in international refereed journals and conferences.
Anand Nayyar, PhD, obtained his doctorate from Desh Bhagat University, Punjab, India in 2017 and is currently an assistant professor at the School of Computer Science, Duy Tan University, Viet Nam. He is also the Vice-Chairman of Research and Director of the IoT and Intelligent Systems Lab at Duy Tan University. He has published more than 180 research articles in international refereed journals, 50 books, and has 100+ patents to his credit. He has more than 12,000 citations on Google Scholar.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Acheter neuf
Afficher cet article
EUR 203,11
Gratuit expédition vers Etats-Unis
Destinations, frais et délaisRésultats de recherche pour Artificial Intelligence and Machine Learning in Drug...
Image d'archives
ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DRUG DESIGN AND DEVELOPMENT (HB 2024)
Vendeur : Basi6 International, Irving, TX, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. N° de réf. du vendeur ABEOCT25-152807
Quantité disponible : 1 disponible(s)
Image d'archives
ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DRUG DESIGN AND DEVELOPMENT (HB 2024)
Vendeur : Romtrade Corp., STERLING HEIGHTS, MI, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. N° de réf. du vendeur ABNR-244662
Quantité disponible : 1 disponible(s)
Image d'archives
ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DRUG DESIGN AND DEVELOPMENT (HB 2024)
Vendeur : SMASS Sellers, IRVING, TX, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed. N° de réf. du vendeur ASNT3-244662
Quantité disponible : 1 disponible(s)
Image d'archives
Artificial Intelligence and Machine Learning in Drug Design and Development
Edité par
John Wiley and Sons, 2024
ISBN 10 : 1394234163
ISBN 13 : 9781394234165
Neuf
Couverture rigide
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur FW-9781394234165
Quantité disponible : 15 disponible(s)
Image d'archives
Artificial Intelligence and Machine Learning in Drug Design and Development (Hardcover)
Edité par
John Wiley & Sons Inc, New York, 2024
ISBN 10 : 1394234163
ISBN 13 : 9781394234165
Neuf
Couverture rigide
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Hardcover. Etat : new. Hardcover. The book is a comprehensive guide that explores the use of artificial intelligence and machine learning in drug discovery and development covering a range of topics, including the use of molecular modeling, docking, identifying targets, selecting compounds, and optimizing drugs. The intersection of Artificial Intelligence (AI) and Machine Learning (ML) within the field of drug design and development represents a pivotal moment in the history of healthcare and pharmaceuticals. The remarkable synergy between cutting-edge technology and the life sciences has ushered in a new era of possibilities, offering unprecedented opportunities, formidable challenges, and a tantalizing glimpse into the future of medicine. AI can be applied to all the key areas of the pharmaceutical industry, such as drug discovery and development, drug repurposing, and improving productivity within a short period. Contemporary methods have shown promising results in facilitating the discovery of drugs to target different diseases. Moreover, AI helps in predicting the efficacy and safety of molecules and gives researchers a much broader chemical pallet for the selection of the best molecules for drug testing and delivery. In this context, drug repurposing is another important topic where AI can have a substantial impact. With the vast amount of clinical and pharmaceutical data available to date, AI algorithms find suitable drugs that can be repurposed for alternative use in medicine. This book is a comprehensive exploration of this dynamic and rapidly evolving field. In an era where precision and efficiency are paramount in drug discovery, AI and ML have emerged as transformative tools, reshaping the way we identify, design, and develop pharmaceuticals. This book is a testament to the profound impact these technologies have had and will continue to have on the pharmaceutical industry, healthcare, and ultimately, patient well-being. The editors of this volume have assembled a distinguished group of experts, researchers, and thought leaders from both the AI, ML, and pharmaceutical domains. Their collective knowledge and insights illuminate the multifaceted landscape of AI and ML in drug design and development, offering a roadmap for navigating its complexities and harnessing its potential. In each section, readers will find a rich tapestry of knowledge, case studies, and expert opinions, providing a 360-degree view of AI and MLs role in drug design and development. Whether you are a researcher, scientist, industry professional, policymaker, or simply curious about the future of medicine, this book offers 19 state-of-the-art chapters providing valuable insights and a compass to navigate the exciting journey ahead. Audience The book is a valuable resource for a wide range of professionals in the pharmaceutical and allied industries including researchers, scientists, engineers, and laboratory workers in the field of drug discovery and development, who want to learn about the latest techniques in machine learning and AI, as well as information technology professionals who are interested in the application of machine learning and artificial intelligence in drug development. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9781394234165
Quantité disponible : 1 disponible(s)
Image d'archives
Artificial Intelligence and Machine Learning in Drug Design and Development (Fintech in a Sustainable Digital Society)
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. In. N° de réf. du vendeur ria9781394234165_new
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Artificial Intelligence and Machine Learning in Drug Design and Development
Edité par
John Wiley & Sons, 2024
ISBN 10 : 1394234163
ISBN 13 : 9781394234165
Neuf
Couverture rigide
Vendeur : moluna, Greven, Allemagne
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. Abhirup Khanna is an assistant professor in the School of Computer Science, University of Petroleum and Energy Studies, Dehradun, India. He has a strong background in education and research. His research areas focus on AI and Blockchain technology and drivi. N° de réf. du vendeur 1215280393
Quantité disponible : Plus de 20 disponibles
Image d'archives
Artificial Intelligence and Machine Learning in Drug Design and Development (Hardcover)
Edité par
John Wiley & Sons Inc, New York, 2024
ISBN 10 : 1394234163
ISBN 13 : 9781394234165
Neuf
Couverture rigide
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Hardcover. Etat : new. Hardcover. The book is a comprehensive guide that explores the use of artificial intelligence and machine learning in drug discovery and development covering a range of topics, including the use of molecular modeling, docking, identifying targets, selecting compounds, and optimizing drugs. The intersection of Artificial Intelligence (AI) and Machine Learning (ML) within the field of drug design and development represents a pivotal moment in the history of healthcare and pharmaceuticals. The remarkable synergy between cutting-edge technology and the life sciences has ushered in a new era of possibilities, offering unprecedented opportunities, formidable challenges, and a tantalizing glimpse into the future of medicine. AI can be applied to all the key areas of the pharmaceutical industry, such as drug discovery and development, drug repurposing, and improving productivity within a short period. Contemporary methods have shown promising results in facilitating the discovery of drugs to target different diseases. Moreover, AI helps in predicting the efficacy and safety of molecules and gives researchers a much broader chemical pallet for the selection of the best molecules for drug testing and delivery. In this context, drug repurposing is another important topic where AI can have a substantial impact. With the vast amount of clinical and pharmaceutical data available to date, AI algorithms find suitable drugs that can be repurposed for alternative use in medicine. This book is a comprehensive exploration of this dynamic and rapidly evolving field. In an era where precision and efficiency are paramount in drug discovery, AI and ML have emerged as transformative tools, reshaping the way we identify, design, and develop pharmaceuticals. This book is a testament to the profound impact these technologies have had and will continue to have on the pharmaceutical industry, healthcare, and ultimately, patient well-being. The editors of this volume have assembled a distinguished group of experts, researchers, and thought leaders from both the AI, ML, and pharmaceutical domains. Their collective knowledge and insights illuminate the multifaceted landscape of AI and ML in drug design and development, offering a roadmap for navigating its complexities and harnessing its potential. In each section, readers will find a rich tapestry of knowledge, case studies, and expert opinions, providing a 360-degree view of AI and MLs role in drug design and development. Whether you are a researcher, scientist, industry professional, policymaker, or simply curious about the future of medicine, this book offers 19 state-of-the-art chapters providing valuable insights and a compass to navigate the exciting journey ahead. Audience The book is a valuable resource for a wide range of professionals in the pharmaceutical and allied industries including researchers, scientists, engineers, and laboratory workers in the field of drug discovery and development, who want to learn about the latest techniques in machine learning and AI, as well as information technology professionals who are interested in the application of machine learning and artificial intelligence in drug development. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9781394234165
Quantité disponible : 1 disponible(s)
Image d'archives
Artificial Intelligence and Machine Learning in Drug Design and Development (Fintech in a Sustainable Digital Society)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. N° de réf. du vendeur 397452541
Quantité disponible : 3 disponible(s)
Image d'archives
Artificial Intelligence and Machine Learning in Drug Design and Development (Fintech in a Sustainable Digital Society)
Edité par
Wiley-Scrivener, 2024
ISBN 10 : 1394234163
ISBN 13 : 9781394234165
Neuf
Couverture rigide
Edition originale
Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlande
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. 2024. 1st Edition. hardcover. . . . . . N° de réf. du vendeur V9781394234165
Quantité disponible : Plus de 20 disponibles